Key result
Beta-blockade partially reverses harmful effects of high adrenergic tone in heart failure.
Why the study?
Congestive heart failure remains a major health problem with high mortality despite existing therapies, necessitating new treatment approaches.
Do beta-blocking agents improve outcomes in patients with congestive heart failure?
Population
Patients with congestive heart failure
Comparison
Beta-adrenergic blockade versus no beta-blocker therapy
Design
Review of recent developments and clinical data
Authors
Loading...
Beta-blockade may benefit heart failure beyond standard therapy; leaves open confirmation in definitive randomized trials.
Do beta-blocking agents improve outcomes in patients with congestive heart failure?
This review highlights the pathophysiological rationale and clinical data supporting the use of beta-blockers to counteract deleterious adrenergic tone in heart failure.
Slatton et al. (1996) conducted a review in congestive heart failure. beta-blocking agents was evaluated. Beta-adrenergic blockade partially reverses the deleterious effects of high adrenergic tone in patients with congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: